Search Results
420 items found for "protein-protein interaction"
- CD28 and chemokine receptors: Signalling amplifiers at the immunological synapse
We also take into account the detrimental effect of mutations carried by distinct signalling proteins
- Adhesion GPCR Consortium Newsletter - May 2024
Transitioning to study Latrophilins, I decided to test the interaction of neurexins with Latrophilins New Insights Members Torsten Schöneberg and Ines Liebscher present an interactive browser-based application the tethered agonist-dependent activities of all 33 aGPCRs in a suite of transcriptional reporter, G protein PMID: 38608683 The activation profile of different G proteins by ADGRL3 is shown using a collection of PMID: 38311610 Member Dimitris Placantonakis’s identifies extended synaptotagmin 1 as an intracellular interaction
- Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor
Nanobody binding stabilizes G-protein-coupled receptors (GPCR) in a fully active state and modulates site and the extracellular domains in conformations modulated by a full agonist, BI167107, and a G-protein-biased
- Adenosine receptor signalling in Alzheimer's disease
Emerging evidence suggests adenosine G protein-coupled receptors (GPCRs) are promising therapeutic targets
- Adenosine receptor signalling in Alzheimer's disease
Emerging evidence suggests adenosine G protein-coupled receptors (GPCRs) are promising therapeutic targets
- GPR110, a receptor for synaptamide, expressed in osteoclasts negatively regulates osteoclastogenesis
Although some G-protein coupled receptors (GPCRs) were reported to play roles in osteoblast function,
- TAS2R supports odontoblastic differentiation of human dental pulp stem cells in the inflammatory...
The G protein and intracellular Ca2+ were detected, respectively, by qPCR and Fluo-4AM Ca2+ fluorescent
- Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology
a biopharmaceutical company specializing in the discovery and development of new drugs targeting G Protein-Coupled
- Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine..
Chemokine Receptor CXCR3 for Autoimmune Diseases "The chemokine receptor CXCR3 is a seven-transmembrane G-protein-coupled
- Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
Numerous intracellular mediators are activated by these G protein-coupled receptors based on several
- Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
Numerous intracellular mediators are activated by these G protein-coupled receptors based on several
- Multifunctional role of GPCR signaling in epithelial tube formation
Rho1 signaling is activated by G-protein-coupled receptor (GPCR) signaling at the cell surface.
- VIB spin-off Confo Therapeutics Enters Collaborative Agreement with Regeneron
platform, which uses conformationally selective VHH antibodies – ConfoBodies® – to stabilize GPCRs (G protein-coupled
- 📰 GPCR Weekly News, April 1 to 7, 2024
through the μ opioid receptor GPCR Binders, Drugs, and more Predicting associations between drugs and G protein-coupled Exhibition June 2 - 7, 2024 | Chemotactic Cytokines June 9 - 14, 2024 | 2024 Phosphorylation and G-Protein
- Multifunctional role of GPCR signaling in epithelial tube formation
Rho1 signaling is activated by G-protein-coupled receptor (GPCR) signaling at the cell surface.
- Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1
September 2022 "Given the promising clinical value of allosteric modulators of G protein-coupled-receptors
- Cholesterol occupies the lipid translocation pathway to block phospholipid scrambling by a GPCR
September 2022 "Class A (rhodopsin-like) G protein-coupled receptors (GPCRs) are constitutive phospholipid We considered whether cholesterol, a prominent component of the plasma membrane, limits the ability of Our analyses reveal that cholesterol inhibits phospholipid scrambling by occupying the TM6/7 interface
- Orion Shares New Data on its Latest Best-in-Class Drug Candidate
Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G Protein-Coupled
- The Gluopsins: Opsins without the Retinal Binding Lysine
They are G-protein-coupled receptors and bind as ligand retinal, which is bound covalently to a lysine
- Fluorescent Ligands Targeting Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2
August 2022 "Fluorescently labeled ligands are versatile molecular tools to study G protein-coupled receptors
- Tracking receptor motions at the plasma membrane reveals distinct effects of ligands on CCR5...
August 2022 "G-protein-coupled receptors (GPCR) are present at the cell surface in different conformational
- Dopamine D 1 receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior...
A major pan-receptor focus has been to identify GPCR-selective ligands that have bias in G protein-dependent
- RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. Lübeck, Germany...
me great pleasure to announce the fourth hybrid symposium on regulatory autoantibodies targeting G-protein-coupled
- New Resources in GPCRdb
Gáspár Pándy-Szekeres ) will present and demonstrate the newest resources of the GPCRdb: 1) the new G protein
- Glucagon receptor-mediated regulation of gluconeogenic gene transcription is endocytosis-dependent..
of gluconeogenic gene transcription is endocytosis-dependent in primary hepatocytes "A number of G protein-coupled
- Keratinocyte-derived defensins activate neutrophil-specific receptors Mrgpra2a/b to prevent skin...
we discovered that the epithelial-cell-derived antimicrobial peptides defensins activated orphan G-protein-coupled
- β-arrestin1 and 2 exhibit distinct phosphorylation-dependent conformations when coupling to the...
to the same GPCR in living cells "β-arrestins mediate regulatory processes for over 800 different G protein-coupled
- Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa
These disorders are mainly related to the abnormalities in the rod G protein-coupled receptor (GPCR),